Keyword Analysis & Research: tptx


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
tptx20.16850704

Keyword Research: People who searched tptx also searched

Keyword CPC PCC Volume Score
tptx1.030.3979234

Search Results related to tptx on Search Engine

  • Bristol Myers Squibb - Bristol Myers Squibb to Acquire Turning …

    bms.com

    https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-to-Acquire-Turning-Point-Therapeutics-a-Leading-Precision-Oncology-Company/default.aspx

    WEBJun 3, 2022 · NEW YORK & SAN DIEGO--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire Turning Point Therapeutics for $76.00 per share. The transaction was unanimously approved by both …

    DA: 72 PA: 78 MOZ Rank: 82

  • TPTX Turning Point Therapeutics Inc - Stocktwits

    stocktwits.com

    https://stocktwits.com/symbol/TPTX

    WEBTrack Turning Point Therapeutics Inc (TPTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

    DA: 90 PA: 11 MOZ Rank: 79

  • TPTX - Turning Point Therapeutics Stock Price - Barchart.com

    barchart.com

    https://www.barchart.com/stocks/quotes/TPTX

    WEBTurning Point Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

    DA: 13 PA: 18 MOZ Rank: 22

  • Turning Point Therapeutics, Inc. Common Stock (TPTX) - Nasdaq

    nasdaq.com

    https://www.nasdaq.com/market-activity/stocks/tptx/real-time

    WEBTurning Point Therapeutics, Inc. Common Stock (TPTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

    DA: 62 PA: 57 MOZ Rank: 64

  • TPTX Stock Doubles On Bristol Myers' $4.1 Billion All-Cash …

    investors.com

    https://www.investors.com/news/technology/tptx-stock-doubles-on-bristol-myers-all-cash-takeover/

    WEBJun 3, 2022 · Licensing. ALLISON GATLIN. 04:14 PM ET 06/03/2022. Turning Point Therapeutics ( TPTX) snagged a $4.1 billion offer from Bristol Myers Squibb ( BMY) on Friday, and TPTX stock more than doubled....

    DA: 84 PA: 2 MOZ Rank: 91


  • Turning Point Therapeutics (NASDAQ: TPTX) - The Motley Fool

    fool.com

    https://www.fool.com/quote/nasdaq/tptx/

    WEBReal time Turning Point Therapeutics (TPTX) stock price quote, stock graph, news & analysis.

    DA: 94 PA: 80 MOZ Rank: 98

  • Turning Point Therapeutics Granted FDA Breakthrough Therapy

    globenewswire.com

    https://www.globenewswire.com/news-release/2020/12/08/2141343/0/en/Turning-Point-Therapeutics-Granted-FDA-Breakthrough-Therapy-Designation-for-Repotrectinib-Treatment-in-Patients-with-ROS1-Positive-Metastatic-Non-Small-Cell-Lung-Cancer-Who-Have-No.html

    WEBSAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of...

    DA: 68 PA: 48 MOZ Rank: 27

  • Turning Point Therapeutics Inc. (TPTX) Stock Price, News

    thestreet.com

    https://www.thestreet.com/quote/TPTX

    WEBJun 3, 2022 · Get the latest Turning Point Therapeutics Inc. (TPTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

    DA: 3 PA: 67 MOZ Rank: 94

  • TPTX Stock Soars 115% as Bristol-Myers Announces ... - InvestorPlace

    investorplace.com

    https://investorplace.com/2022/06/tptx-stock-soars-115-as-bristol-myers-announces-takeover-of-turning-point-therapeutics/

    WEBJun 3, 2022 · Turning Point Therapeutics (NASDAQ: TPTX) is rising on acquisition news. Bristol-Myers Squibb (NYSE: BMY) is buying the company for $76 per share. TPTX’s repotrectinib is a major factor in...

    DA: 4 PA: 57 MOZ Rank: 45

  • Bristol Myers Squibb To Acquire Turning Point Therapeutics

    nasdaq.com

    https://www.nasdaq.com/articles/bristol-myers-squibb-to-acquire-turning-point-therapeutics-quick-facts

    WEBPublished. Jun 3, 2022 09:14AM EDT. (RTTNews) - Bristol Myers Squibb (BMY) and Turning Point Therapeutics, Inc. (TPTX) announced a merger deal, under which Bristol Myers Squibb will acquire...

    DA: 90 PA: 42 MOZ Rank: 75